Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice (Q45737380)

15 December 2017

Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice (English)

1 reference

15 December 2017

0 references

0 references

1 reference

9

1 reference

15 December 2017

Alexandre C Santana

1

1 reference

15 December 2017

Sabrina Degaspari

2

1 reference

15 December 2017

Sergio Catanozi

3

1 reference

15 December 2017

Humberto Dellê

4

1 reference

15 December 2017

Larissa de Sá Lima

5

1 reference

15 December 2017

Cleonice Silva

6

1 reference

15 December 2017

Paula Blanco

7

1 reference

15 December 2017

Kim Solez

8

1 reference

15 December 2017

Irene L Noronha

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

22 January 2013

1 reference

Nephrology Dialysis Transplantation

15 December 2017

1 reference

15 December 2017

28

1 reference

15 December 2017

1140-1149

1 reference

15 December 2017

5

1 reference

Immunological basis of inflammation in dialysis

15 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

One-year open-label trial of thalidomide in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Clinical pharmacokinetics of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in thalidomide- treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Antifibrotic effect of tamoxifen in a model of progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Thalidomide inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endometriotic stromal cells, possibly through suppression of nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS569

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS569

1 reference

15 December 2017

1 reference